SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,364.87 |
| Enterprise Value ($M) | 1,231.85 |
| Book Value ($M) | 366.43 |
| Book Value / Share | 4.29 |
| Price / Book | 3.72 |
| NCAV ($M) | 355.43 |
| NCAV / Share | 4.16 |
| Price / NCAV | 3.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.81 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.99 |
| Current Ratio | 6.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 414.81 |
| Assets | 425.81 |
| Liabilities | 59.38 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Kynam Capital Management, LP | |||
| 13G | Goldman Sachs Group Inc | |||
| 13G | Morgan Stanley | |||
| 13G | Point72 Asset Management, L.P. | |||
| 13G/A | BlackRock, Inc. | 10.30 | 6.66 | |
| 13G/A | Wellington Management Group Llp | 5.86 | -34.27 | |
| 13G/A | State Street Corp | 4.40 | -24.83 | |
| 13G/A | Avidity Partners Management LP | 4.70 | -41.20 | |
| 13G | Vanguard Group Inc | 5.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| 84,826,632 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 922,035 | 3,248,661 | 28.38 | |
| 480,339 | 1,811,139 | 26.52 | |
| 100,184 | 722,112 | 13.87 | |
| 128,093 | 829,188 | 15.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SDGR – Schrödinger, Inc. | SLDB – Solid Biosciences Inc. |
| SLRN – Acelyrin, Inc. | SPRO – Spero Therapeutics, Inc. |
| SRPT – Sarepta Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io